Paper40649751
Tumor-Associated Macrophage in Breast Tumor Microenvironment.
Ma L and 3 others. Int J Mol Sci, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Tumor-Associated Macrophage in Breast Tumor Microenvironment. Papers, record 40649751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40649751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Breast Neoplasms | Major topic |
| Tumor-Associated Macrophages | Major topic |
| Humans | |
| Female | |
| Animals | |
| Neovascularization, Pathologic |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 81501817 | the National Natural Science Foundation of China | PubMed | ||
| 82202610 | the National Natural Science Foundation of China | PubMed | ||
| ZDXK202239 | the Jiangsu Province Capability Improvement Project through Science, Technology and Education | PubMed |
Source PubMed
References238
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25035124 | Targeting cancer-derived adenosine: new therapeutic approaches. | Cancer Discov | 2014 | https://conductscience.org/library/papers/25035124 | PubMed |
| 2 | 27562774 | Diverse macrophages polarization in tumor microenvironment. | Arch Pharm Res | 2016 | https://conductscience.org/library/papers/27562774 | PubMed |
| 3 | 27271610 | Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27271610 | PubMed |
| 4 | 34678411 | ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. | Ann Oncol | 2021 | https://conductscience.org/library/papers/34678411 | PubMed |
| 5 | 31429357 | The Angiopoietin ligands and Tie receptors: potential diagnostic biomarkers of vascular disease. | J Recept Signal Transduct Res | 2019 | https://conductscience.org/library/papers/31429357 | PubMed |
| 6 | 36333630 | NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer. | Apoptosis | 2023 | https://conductscience.org/library/papers/36333630 | PubMed |
| 7 | 30728668 | Single Cell Omics of Breast Cancer: An Update on Characterization and Diagnosis. | Indian J Clin Biochem | 2019 | https://conductscience.org/library/papers/30728668 | PubMed |
| 8 | 16169466 | Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. | Cancer Cell | 2005 | https://conductscience.org/library/papers/16169466 | PubMed |
| 9 | 26612575 | Addendum: A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. | Nat Cell Biol | 2015 | https://conductscience.org/library/papers/26612575 | PubMed |
| 10 | 29849822 | CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression. | Dis Markers | 2018 | https://conductscience.org/library/papers/29849822 | PubMed |
| 11 | 35168767 | Disparities in Breast Cancer. | Obstet Gynecol Clin North Am | 2022 | https://conductscience.org/library/papers/35168767 | PubMed |
| 12 | 24912655 | CSF-1R signaling in health and disease: a focus on the mammary gland. | J Mammary Gland Biol Neoplasia | 2014 | https://conductscience.org/library/papers/24912655 | PubMed |
| 13 | 27745970 | L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity. | Cell | 2016 | https://conductscience.org/library/papers/27745970 | PubMed |
| 14 | 21481792 | Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. | Cancer Cell | 2011 | https://conductscience.org/library/papers/21481792 | PubMed |
| 15 | 28974683 | Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs. | Nat Commun | 2017 | https://conductscience.org/library/papers/28974683 | PubMed |
| 16 | 25959051 | Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. | Integr Biol (Camb) | 2015 | https://conductscience.org/library/papers/25959051 | PubMed |
| 17 | 31720082 | Recruitment of monocytes and epigenetic silencing of intratumoral CYP7B1 primarily contribute to the accumulation of 27-hydroxycholesterol in breast cancer. | Am J Cancer Res | 2019 | https://conductscience.org/library/papers/31720082 | PubMed |
| 18 | 29902924 | Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker. | Biomark Med | 2018 | https://conductscience.org/library/papers/29902924 | PubMed |
| 19 | 35469015 | Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs. | Nat Cancer | 2022 | https://conductscience.org/library/papers/35469015 | PubMed |
| 20 | 33150908 | A parallel and cascade control system: magnetofection of miR125b for synergistic tumor-association macrophage polarization regulation and tumor cell suppression in breast cancer treatment. | Nanoscale | 2020 | https://conductscience.org/library/papers/33150908 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42513228 | Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms. | Molecules | 2026 | https://conductscience.org/library/papers/42513228 | PubMed |
| 42212312 | Targeting Tumor-Associated Macrophages to Reshape the Immuno-Mechanical Landscape: Molecular Mechanisms and Therapeutic Strategies. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42212312 | PubMed |
| 42093035 | The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancer. | Breast Cancer Res | 2026 | https://conductscience.org/library/papers/42093035 | PubMed |
| 41001838 | Comprehensive Pan-Cancer Analysis of TRNT1 as a Potential Biomarker for Breast Cancer. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/41001838 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40649751
GET https://conductscience.org/api/papers/v1/40649751/references?page=2